Near Infra-red Spectroscopy for Detection of Intracranial Haematoma

Traumatic Brain Injury Clinical Trial

Official title:

Non-invasive Neuro-monitoring for Head Injury: Use of Near Infra-red Spectroscopy for Early Detection of Delayed Intracranial Haematoma

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT03653728
• Other study ID #: NTEC-2018-0106
• Status: Not yet recruiting
• Start date: April 1, 2022
• Est. completion date: March 31, 2023

Study information

• Verified date: July 2021
• Source: Chinese University of Hong Kong
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

Fall with head injury is becoming an epidemic challenge especially with the ageing population. Contributing factors for mortality and poor functional outcome included development of cerebral contusion and delayed traumatic intracerebral haematoma. There is a higher prevalence especially with the increasing use of antiplatelets and anticoagulants.

Non-invasive monitoring such as near-infrared spectroscopy (NIRS) is sensitive in detecting intracranial changes. The role and efficacy of this non-invasive method has not been specifically established in patients with head injury as an initial non-operative monitoring. This is particular important in the setting of a general ward in which nursing staff is limited. The advantages of these noninvasive monitoring might have a role of continuous neuro-monitoring. They can also potentially reduce the number of unnecessary repeated CT Brain in the context of limited radiology staff and resources. Timely detection and treatment of this condition accordingly is crucial. Potential options of non-invasive monitoring such as nearinfrared spectroscopy (NIRS) is to be investigated.

The aim of this study is to determine the sensitivity and specificity of NIRS as a non-invasive monitoring in detecting delayed intracranial injuries in comparison with the Gold Standard CT Brain. Study design is Prospective sensitivity and specificity study of Near Infra-red Spectroscopy (NIRS) as a non-invasive monitoring in detecting delayed intracranial injuries in comparison with the Gold Standard CT Brain in Hong Kong Chinese. Consecutive patients admitted to Prince of Wales Hospital, Hong Kong would be recruited. Outcome measures including correlation of non-invasive monitoring with near-infrared spectroscopy (NIRS) to CT Brain findings including any increase in haematoma size, cerebral edema or mass effect. Secondary outcome including 30 days mortality and functional outcome at 3 months.

Description:

Introduction: Fall with head injury is becoming an epidemic challenge especially with the ageing population. Contributing factors for mortality and poor functional outcome included development of cerebral contusion and delayed traumatic intracerebral haematoma. There is a higher prevalence especially with the increasing use of antiplatelets and anticoagulants.

Non-invasive monitoring such as near-infrared spectroscopy (NIRS) is sensitive in detecting intracranial changes. The role and efficacy of this non-invasive method has not been specifically established in patients with head injury as an initial non-operative monitoring. This is particular important in the setting of a general ward in which nursing staff is limited. The advantages of these non-invasive monitoring might have a role of continuous neuro-monitoring. They can also potentially reduce the number of unnecessary repeated CT Brain in the context of limited radiology staff and resources.

Timely detection and treatment of this condition accordingly is crucial. Potential options of non-invasive monitoring such as near-infrared spectroscopy (NIRS) is to be investigated.

Aims and Hypotheses to be tested:

The aim of this study is to determine the sensitivity and specificity of near-infrared spectroscopy (NIRS) as a non-invasive monitoring in detecting delayed intracranial injuries in comparison with the Gold Standard CT Brain.

Plan of Investigation:

This is a prospective sensitivity and specificity correlation study of Near Infra-red Spectroscopy (NIRS) as a non-invasive monitoring in detecting delayed intracranial injuries in comparison with the Gold Standard CT Brain in Hong Kong Chinese. Consecutive patients admitted to Prince of Wales Hospital, Hong Kong would be recruited.

Consecutive patients fulfilling the inclusion and exclusion criteria are treated with standard of care with near-infrared spectroscopy (NIRS). Criteria to proceed for repeat CT Brain scan 1) clinical deterioration of GCS >2 points, 2) NIRS monitoring has increase in difference in absorbance of light at 760nm >0.3, or 3) 8 hours after admission for baseline interval scan for all patients as part of the standard of care. Non-invasive monitoring with near-infrared spectroscopy (NIRS) would be applied to all patients' forehead for consecutively 48 hours after admission.

Inclusion criteria

1. Age greater than or equal to 18 years old,

2. History of traumatic brain injury,

3. Radiological evidence of intracranial haematoma,

4. Glasgow Coma Scale (GCS) less than 15 upon admission,

5. Not undergoing immediate operation,

6. Admission to the general ward or high dependence unit of Neurosurgery, Prince of Wales Hospital.

Exclusion criteria

1. Presence of frontal scalp laceration preventing the application of non-invasive monitoring on the forehead,

2. Presence of pneumocephale,

3. Requirement of immediate surgical intervention as judged by the on-call neurosurgeon.

4. Patients who have joined other drug trial in the last four weeks;

5. Pregnant or on breast feeding;

6. Any other reasons that the researchers consider unsuitable.

Primary outcome - Correlation coefficient of near-infrared spectroscopy (NIRS) to CT Brain findings including any increase in haematoma size, cerebral edema or mass effect.

Secondary outcomes

• Secondary outcome including number of CT scan performed, correlation of NIRS reading with Glasgow coma scale (GCS), rate of intervention with either medical treatment such as use of mannitol, Transamin or blood product transfusion, or surgical treatment such as operation, 30 days mortality and functional outcome at 3 months.

Purpose and Potential:

Near-infrared spectroscopy (NIRS) can offer continuous neuro-monitoring. This is particular important in the setting of a general ward in which nursing staff is limited. This allows early detection of delayed haematoma for early intervention. At the same time, the use of NIRS can potentially reduce the number of unnecessary repeated CT Brain in the context of limited radiology staff and resources.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 24
• Est. completion date: March 31, 2023
• Est. primary completion date: March 31, 2023
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

1. Age greater than or equal to 18 years old,

2. History of traumatic brain injury,

3. Radiological evidence of intracranial haematoma,

4. Glasgow Coma Scale (GCS) less than 15 upon admission,

5. Not undergoing immediate operation,

6. Admission to the general ward or high dependence unit of Neurosurgery, Prince of Wales Hospital.

Exclusion Criteria:

1. Presence of frontal scalp laceration preventing the application of non-invasive monitoring on the forehead,

2. Presence of pneumocephale,

3. Requirement of immediate surgical intervention as judged by the on-call neurosurgeon.

4. Patients who have joined other drug trial in the last four weeks;

5. Pregnant or on breast feeding;

6. Any other reasons that the researchers consider unsuitable.

Related Conditions & MeSH terms

• Brain Injuries
• Brain Injuries, Traumatic
• Cerebral Hemorrhage
• Hematoma
• Hemorrhage
• Intracerebral Hemorrhage
• Traumatic Brain Injury

Intervention

Device:
• Near infrared spectroscopy
All patients would be receiving the same treatment including application of non-invasive monitoring with near-infrared spectroscopy (NIRS) together with the standard of care with interval CT Brain scan for all patients. Non-invasive monitoring with near-infrared spectroscopy (NIRS) is very safe and is in current daily routine clinical use for intraoperative patients.

Locations

Country	Name	City	State
Hong Kong	Division of Neurosurgery, Department of Surgery, Prince of Wales Hospital, Hong Kong	Hong Kong

Sponsors (1)

Lead Sponsor	Collaborator
Chinese University of Hong Kong

Country where clinical trial is conducted

Hong Kong, 

References & Publications (11)

Alahmadi H, Vachhrajani S, Cusimano MD. The natural history of brain contusion: an analysis of radiological and clinical progression. J Neurosurg. 2010 May;112(5):1139-45. doi: 10.3171/2009.5.JNS081369. Review. — View Citation

Chang EF, Meeker M, Holland MC. Acute traumatic intraparenchymal hemorrhage: risk factors for progression in the early post-injury period. Neurosurgery. 2006 Apr;58(4):647-56; discussion 647-56. — View Citation

Chieregato A, Fainardi E, Morselli-Labate AM, Antonelli V, Compagnone C, Targa L, Kraus J, Servadei F. Factors associated with neurological outcome and lesion progression in traumatic subarachnoid hemorrhage patients. Neurosurgery. 2005 Apr;56(4):671-80; discussion 671-80. — View Citation

Folkerson LE, Sloan D, Cotton BA, Holcomb JB, Tomasek JS, Wade CE. Predicting progressive hemorrhagic injury from isolated traumatic brain injury and coagulation. Surgery. 2015 Sep;158(3):655-61. doi: 10.1016/j.surg.2015.02.029. Epub 2015 Jun 9. — View Citation

Gomersall CD, Joynt GM, Gin T, Freebairn RC, Stewart IE. Failure of the INVOS 3100 cerebral oximeter to detect complete absence of cerebral blood flow. Crit Care Med. 1997 Jul;25(7):1252-4. — View Citation

Gomersall CD, Leung PL, Gin T, Joynt GM, Young RJ, Poon WS, Oh TE. A comparison of the Hamamatsu NIRO 500 and the INVOS 3100 near-infrared spectrophotometers. Anaesth Intensive Care. 1998 Oct;26(5):548-57. — View Citation

Kim B, Jeong H, Kim J, Kim T, Kim K, Lee H, Ahn S, Jo YH, Lee JH, Hwang JE. Incidence and risk factors of delayed intracranial hemorrhage in the emergency department. Am J Emerg Med. 2018 Feb;36(2):271-276. doi: 10.1016/j.ajem.2017.08.009. Epub 2017 Aug 4. — View Citation

Narayan RK, Maas AI, Servadei F, Skolnick BE, Tillinger MN, Marshall LF; Traumatic Intracerebral Hemorrhage Study Group. Progression of traumatic intracerebral hemorrhage: a prospective observational study. J Neurotrauma. 2008 Jun;25(6):629-39. doi: 10.1089/neu.2007.0385. — View Citation

Oertel M, Kelly DF, McArthur D, Boscardin WJ, Glenn TC, Lee JH, Gravori T, Obukhov D, McBride DQ, Martin NA. Progressive hemorrhage after head trauma: predictors and consequences of the evolving injury. J Neurosurg. 2002 Jan;96(1):109-16. — View Citation

Poon WS, Wong GK, Ng SC. The quantitative time-resolved near infrared spectroscopy (TR-NIRs) for bedside cerebrohemodynamic monitoring after aneurysmal subarachnoid hemorrhage: can we predict delayed neurological deficits? World Neurosurg. 2010 May;73(5):465-6. doi: 10.1016/j.wneu.2010.03.029. — View Citation

Weigl W, Milej D, Janusek D, Wojtkiewicz S, Sawosz P, Kacprzak M, Gerega A, Maniewski R, Liebert A. Application of optical methods in the monitoring of traumatic brain injury: A review. J Cereb Blood Flow Metab. 2016 Nov;36(11):1825-1843. Epub 2016 Sep 7. Review. — View Citation

* Note: There are 11 references in all — Click here to view all references

Outcome

Type	Measure	Description	Time frame	Safety issue
Other	correlation of NIRS reading with Glasgow coma scale (GCS)	correlation of NIRS reading with Glasgow coma scale (GCS). The scale GCS ranges from 3 to 15, in which a GCS of 3 indicates a status of deep coma, whereas a GCS of 15 indicates a fully conscious status.	1 week
Other	Number of CT performed	Number of CT performed	1 week
Other	Other intervention such as blood product transfusion or operation	Other intervention such as blood product transfusion or operation	1 week
Primary	Correlation coefficient	Correlation coefficient of near-infrared spectroscopy (NIRS) to CT Brain findings including any increase in haematoma size, cerebral edema or mass effect.	1 week
Secondary	30 days mortality	30 days mortality	30 days
Secondary	modified Rankin Scale	modified Rankin Scale (mRS) at 3 months. The mRS scale ranges from 0 to 6, in which 0 indicates no disability, while 6 indicates death.	3 months